Literature DB >> 19798462

Validation and application of a method for the determination of total chromium in rat tissues by inductively coupled plasma mass spectrometry.

Keith E Levine1, Matthew D Stout, Glenn T Ross, Amal S Essader, Frank X Weber, Peter M Grohse, Reshan A Fernando, Lisa S Milstein, Michelle J Hooth, Bradley J Collins.   

Abstract

The validation of a method for the determination of chromium (Cr) in F-344/N rat tissues by inductively coupled plasma-mass spectrometry is described. Samples were analyzed after a rapid, open-vessel microwave digestion procedure. Performance of the method was evaluated using kidney tissue across a concentration range of 0.50-5.00 microg Cr/g tissue. Data for method linearity, accuracy, precision, digest stability, and storage stability are presented along with limits of detection and quantitation data. Data from a method cross-validation for B6C3F1 mouse kidney tissue are also presented. After validation, the method was applied to analyze samples collected in support of two chronic toxicity and carcinogenesis studies conducted by the National Toxicology Program.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19798462     DOI: 10.1007/s00244-009-9397-5

Source DB:  PubMed          Journal:  Arch Environ Contam Toxicol        ISSN: 0090-4341            Impact factor:   2.804


  2 in total

1.  Exposure to hexavalent chromium resulted in significantly higher tissue chromium burden compared with trivalent chromium following similar oral doses to male F344/N rats and female B6C3F1 mice.

Authors:  Bradley J Collins; Matthew D Stout; Keith E Levine; Grace E Kissling; Ronald L Melnick; Timothy R Fennell; Ramsey Walden; Kamal Abdo; John B Pritchard; Reshan A Fernando; Leo T Burka; Michelle J Hooth
Journal:  Toxicol Sci       Date:  2010-09-15       Impact factor: 4.849

2.  Evaluating the Impact of the U.S. National Toxicology Program: A Case Study on Hexavalent Chromium.

Authors:  Yun Xie; Stephanie Holmgren; Danica M K Andrews; Mary S Wolfe
Journal:  Environ Health Perspect       Date:  2016-08-02       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.